Purchase Short-Term Access

Is Improved Survival a Class Effect of Angiotensin-Converting Enzyme Inhibitors?
Sean Hennessy, PharmD, PhD; Stephen E. Kimmel, MD, MSCE
Annals of Internal Medicine 2004;141:157-158. doi:10.7326/0003-4819-141-2-200407200-00016

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.